TN2014000127A1 - EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME - Google Patents
EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAMEInfo
- Publication number
- TN2014000127A1 TN2014000127A1 TNP2014000127A TN2014000127A TN2014000127A1 TN 2014000127 A1 TN2014000127 A1 TN 2014000127A1 TN P2014000127 A TNP2014000127 A TN P2014000127A TN 2014000127 A TN2014000127 A TN 2014000127A TN 2014000127 A1 TN2014000127 A1 TN 2014000127A1
- Authority
- TN
- Tunisia
- Prior art keywords
- rapid
- producing
- effective
- pharmaceutical composition
- same
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention a pour objet des compositions pharmaceutiques effervescentes à désagrégation rapide destinés à l'administration par voie orale d'un glucorticoïde : le prednisolone métasulfobenzoate à titre de principe actif, sous forme d'ester libre ou de sel pharmaceutiquement actif. Les dites compositions se caractérisent par un temps de désagrégation inférieur à une minute, une teneur atténuée voire nulle en sodium et elles offrent un supplément de potassium permettant de compenser la fuite potassique pouvant être provoquée par le principe actif.The subject of the present invention is fast-disintegrating effervescent pharmaceutical compositions intended for the oral administration of a glucocorticoid: the prednisolone metasulfobenzoate as active principle, in the form of a free ester or of a pharmaceutically active salt. The said compositions are characterized by a disintegration time of less than one minute, an attenuated or even no sodium content and they offer a potassium supplement making it possible to compensate for the potassium leakage that may be caused by the active principle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TNP2014000127A TN2014000127A1 (en) | 2014-03-26 | 2014-03-26 | EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TNP2014000127A TN2014000127A1 (en) | 2014-03-26 | 2014-03-26 | EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2014000127A1 true TN2014000127A1 (en) | 2015-07-01 |
Family
ID=59742305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2014000127A TN2014000127A1 (en) | 2014-03-26 | 2014-03-26 | EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2014000127A1 (en) |
-
2014
- 2014-03-26 TN TNP2014000127A patent/TN2014000127A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ742220A (en) | Pharmaceutical compositions comprising meloxicam | |
CY1124052T1 (en) | ORALLY DISPERSIBLE TABLET CONTAINING ESTETROL | |
MX2016010213A (en) | Novel pharmaceutical formulations. | |
MA38399A1 (en) | Formulation in tablet form, useful for treating acute heart failure and chronic heart failure | |
EA201691242A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AZD9291 | |
MA53399B1 (en) | Substituted pyrazoles as inhibitors of human plasma kallikrein | |
EA201691454A1 (en) | COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING | |
MA32692B1 (en) | METHOD FOR RELEASING A PHARMACEUTICAL COMPOSITION FROM A PATIENT THAT NEEDS | |
MX2013014788A (en) | Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids. | |
MA45598B1 (en) | 24-hydroxy steroles substituted in position 11 for the treatment of diseases linked to the nmda receptor | |
MA38576B2 (en) | Sustained-release colchicine formulations and methods of use thereof | |
MA35753B1 (en) | Aryl-dihydropyridinones and piperidinones as mgat2 inhibitors | |
PH12017502416A1 (en) | 17-hydroxyprogesterone ester-containing oral compositions and related methods | |
MX2020010300A (en) | Mono-(acid) salts of 6-aminoisoquinolines and uses thereof. | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
MX369571B (en) | Composition for preventing or treating fatty liver diseases. | |
MA43052B1 (en) | Human Plasma Kallikrein Inhibitors | |
EA201990765A1 (en) | AZAINDAZOLE COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments | |
MX2021002902A (en) | Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing gpr119 ligand as active ingredient. | |
JOP20180071B1 (en) | Use of aminoalkylbenzothiazepine derivatives | |
RU2013110517A (en) | MEANS FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHEPATITIS | |
EA201990766A1 (en) | INDOSOLIC COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments | |
EA201892842A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID | |
FR3050112B1 (en) | USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES | |
TN2014000127A1 (en) | EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME |